Original Research
Published on 28 May 2020
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
in Headache and Neurogenic Pain
- 8,565 views
- 77 citations